跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,571 条关于
“Cullinan Oncology”
全部
10,571
临床试验
2,012
药物
146
机构
256
资讯
8,157
4年前
Cullinan Oncology and Taiho Pharmaceutical Forge $275M Strategic Collaboration for EGFR Inhibitor CLN-081/TAS6417
2年前
Adimab Announces 2023 Clinical Pipeline Update with 12 New Partner Programs
去年
Merck & Co. Acquires Curon Bio's Bispecific T-Cell Engager for $1.3 Billion
去年
Cullinan Therapeutics Licenses BCMA-Targeted Bispecific T Cell Engager for Autoimmune Disease Development
上个月
Zipalertinib Plus Chemotherapy Meets Primary Endpoint in Phase 3 REZILIENT3 Trial for First-Line EGFR Exon 20 Insertion NSCLC
4个月前
Analysts Maintain Strong Buy Consensus on Cullinan Management (CGEM) with Significant Upside Potential
去年
Cullinan Therapeutics Advances Novel CD19 T Cell Engager for Autoimmune Disease Treatment
上个月
Cullinan Therapeutics Reports $53.7 Million Q2 Loss, Missing Analyst Expectations
8天前
Cullinan's Zipalertinib Plus Chemotherapy Hits Primary Endpoint in Phase 3 REZILIENT3, Interim Data Headed to WCLC Presidential Symposium
去年
Cullinan Management's Zipalertinib Shows Promise in NSCLC, Bolstering Stock Rating
第 1 页,共 816 页
上一页
下一页